NCT05320211 is a NA clinical trial of 3D-printed hand orthosis in Hand Injuries and Disorders, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Who is sponsoring NCT05320211?

NCT05320211 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

What drugs are being tested in NCT05320211?

Interventions in NCT05320211: 3D-printed hand orthosis.

What condition does NCT05320211 study?

NCT05320211 studies Hand Injuries and Disorders.

Is NCT05320211 still recruiting?

NCT05320211 is currently completed. Last updated 31 March 2023.

Last reviewed 2023-03-31 · How we verify

NCT05320211

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Three-dimensional Printed Hand Orthoses

Completed NA Last updated 31 March 2023

What this trial tests

NA trial testing 3D-printed hand orthosis in Hand Injuries and Disorders in 21 participants. Completed in 28 February 2023.

Timeline

12 April 2022

Primary endpoint
28 February 2023

28 February 2023

Quick facts

Lead sponsor	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	21
Start date	12 April 2022
Primary completion	28 February 2023
Estimated completion	28 February 2023
Sites	1 location across Netherlands

Drugs / interventions tested

3D-printed hand orthosis

Conditions studied

Hand Injuries and Disorders — all drugs for Hand Injuries and Disorders →

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — full company profile →

Who can join

18 and older, any sex, with Hand Injuries and Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In persons with chronic hand conditions, orthoses are often prescribed to improve daily-life functioning. In most cases, orthoses are custom manufactured based on a plaster hand model, which is a time-consuming and labor-intensive process. It has been demonstrated that the production time to custom manufacture hand orthoses can be greatly reduced by using three-dimensional (3D) scanning and printing, offering a promising cost-effective alternative to conventional costum manufactured hand orthoses. However, before setting up a cost-effectiveness study in persons with chronic hand conditions, insight into the effectiveness of 3D-printed orthoses on performance of activities of daily living (ADL) is needed, as well as insight into potential cost reductions. To date, this information is largely unknown. The aims of this feasibility study are 1) to collect data on the preliminary effectiveness of 3D-printed orthoses on performance of ADL, satisfaction with the orthosis and quality of life compared to conventional orthoses in persons with chronic hand conditions, and 2) to compare the production time and costs of 3D-printed orthoses with conventional orthoses.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Preliminary effectiveness of 3D-printed orthoses in chronic hand conditions: study protocol for a non-randomised interventional feasibility study.
Oud T, Tuijtelaars J, Bogaards H, Nollet F, et al · · 2023 · cited 6× · PMID 37024252 · DOI 10.1136/bmjopen-2022-069424
Validity and reliability of the Dutch translation of the OPUS' client satisfaction with device module in chronic users of hand orthoses.
Oud T, Tuijtelaars J, Schenk J, Nollet F, et al · · 2023 · cited 3× · PMID 37605151 · DOI 10.1186/s12955-023-02181-3
Preliminary effectiveness and production time and costs of three-dimensional printed orthoses in chronic hand conditions: an interventional feasibility study.
Oud T, Bogaards JA, Nollet F, Brehm MA. · · 2024 · cited 1× · PMID 38742877 · DOI 10.2340/jrm.v56.39946

Verify or expand the search:

Other recruiting trials for Hand Injuries and Disorders

Currently open trials in the same condition.

NCT04460521 — The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome · Phase 4 · recruiting

Other Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials

Trials by the same sponsor.

NCT07301021 — Velopharyngeal Insufficiency After Maxillomandibular Advancement Osteotomy in Obstructive Sleep Apnea Patients · not yet recruiting
NCT07359482 — sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 · Phase 3 · not yet recruiting
NCT07457957 — Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents · NA · not yet recruiting
NCT06909045 — Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease · NA · recruiting
NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05320211 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Last refreshed: 31 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05320211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing